Perrigo Company plc Shares Outstanding (Cover Page)
Perrigo Company plc (PRGO) had Shares Outstanding (Cover Page) of 138.77 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 138.77M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 138.37M shares.
- 2026-02-24: Entity Common Stock, Shares Outstanding 137.65M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 137.62M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 138.77M shares 10-Q · filed 2026-08-05 |
| 2026-05-01 | 138.37M shares 10-Q · filed 2026-05-06 |
| 2026-02-24 | 137.65M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 137.62M shares 10-Q · filed 2025-11-05 |
| 2025-08-01 | 137.58M shares 10-Q · filed 2025-08-06 |
| 2025-05-02 | 137.48M shares 10-Q · filed 2025-05-07 |
| 2025-02-21 | 136.46M shares 10-K · filed 2025-02-28 |
| 2024-11-04 | 136.43M shares 10-Q · filed 2024-11-06 |
| 2024-07-31 | 136.42M shares 10-Q · filed 2024-08-02 |
| 2024-05-03 | 136.32M shares 10-Q · filed 2024-05-07 |
| 2024-02-23 | 135.52M shares 10-K · filed 2024-02-27 |
| 2023-11-03 | 135.51M shares 10-Q · filed 2023-11-07 |
| 2023-08-04 | 135.40M shares 10-Q · filed 2023-08-08 |
| 2023-05-05 | 135.33M shares 10-Q · filed 2023-05-09 |
| 2023-02-24 | 134.65M shares 10-K · filed 2023-02-28 |
| 2022-11-04 | 134.64M shares 10-Q · filed 2022-11-08 |
| 2022-08-05 | 134.62M shares 10-Q · filed 2022-08-09 |
| 2022-05-06 | 134.55M shares 10-Q · filed 2022-05-11 |
| 2022-02-25 | 133.78M shares 10-K · filed 2022-03-01 |
| 2021-11-05 | 133.77M shares 10-Q · filed 2021-11-12 |
| 2021-08-06 | 133.71M shares 10-Q · filed 2021-08-11 |
| 2021-05-07 | 133.55M shares 10-Q · filed 2021-05-12 |
| 2021-02-26 | 133.10M shares 10-K · filed 2021-03-01 |
| 2020-10-30 | 136.49M shares 10-Q · filed 2020-11-05 |
| 2020-07-31 | 136.48M shares 10-Q · filed 2020-08-05 |
| 2020-05-01 | 136.31M shares 10-Q · filed 2020-05-05 |
| 2020-02-21 | 136.13M shares 10-K · filed 2020-02-27 |
| 2019-11-01 | 136.11M shares 10-Q · filed 2019-11-06 |
| 2019-08-02 | 136.05M shares 10-Q · filed 2019-08-08 |
| 2019-05-03 | 135.99M shares 10-Q · filed 2019-05-09 |
| 2019-02-22 | 135.87M shares 10-K · filed 2019-02-27 |
| 2018-11-02 | 135.86M shares 10-Q · filed 2018-11-08 |
| 2018-08-03 | 136.83M shares 10-Q · filed 2018-08-09 |
| 2018-05-04 | 138.46M shares 10-Q · filed 2018-05-08 |
| 2018-02-23 | 140.83M shares 10-K · filed 2018-03-01 |
| 2017-09-30 | 140.84M shares 10-Q · filed 2017-11-09 |
| 2017-07-01 | 142.61M shares 10-Q · filed 2017-08-10 |
| 2017-05-26 | 143.40M shares 10-Q · filed 2017-05-30 |
| 2017-02-24 | 143.40M shares 10-K · filed 2017-05-22 |
| 2016-11-04 | 143.37M shares 10-Q/A · filed 2017-05-23 |
| 2016-08-05 | 143.28M shares 10-Q/A · filed 2017-05-22 |
| 2016-05-06 | 143.22M shares 10-Q/A · filed 2017-05-22 |
| 2016-02-19 | 143.20M shares 10-KT · filed 2016-02-25 |
| 2015-10-30 | 146.40M shares 10-Q · filed 2015-11-02 |
| 2015-08-07 | 146.28M shares 10-K · filed 2015-08-13 |
| 2015-04-24 | 146.26M shares 10-Q · filed 2015-04-29 |
| 2015-01-30 | 140.79M shares 10-Q · filed 2015-02-05 |
| 2014-10-31 | 133.96M shares 10-Q · filed 2014-11-06 |
| 2014-08-08 | 133.82M shares 10-K · filed 2014-08-14 |
| 2014-05-02 | 133.80M shares 10-Q · filed 2014-05-07 |
| 2014-01-31 | 133.75M shares 10-Q · filed 2014-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |